How has been the historical performance of Maitreya Medica.?

Answer:The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, decreasing from INR 49.41 crore to INR 46.66 crore over the same period. The company's total expenditure, excluding depreciation, decreased from INR 46.05 crore in March 2022 to INR 41.80 crore in March 2025, contributing to an operating profit (PBDIT) that rose from INR 3.36 crore in March 2022 to INR 4.86 crore in March 2025, despite a dip in the operating profit margin from 18.41% in March 2023 to 10.42% in March 2025. Profit before tax also fluctuated, peaking at INR 5.93 crore in March 2023 before falling to INR 3.21 crore in March 2025. The profit after tax followed a similar pattern, reaching INR 4.25 crore in March 2023 and dropping to INR 1.87 crore in March 2025. On the balance sheet, total assets increased from INR 24.49 crore in March 2022 to INR 47.99 crore in March 2025, while total liabilities rose from INR 24.49 crore to INR 47.99 crore in the same timeframe. Cash flow from operating activities improved significantly, moving from INR 0.00 crore in March 2022 to INR 5.00 crore in March 2025, indicating a positive trend in cash generation.